You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 273 No. 24, June 28, 1995 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Serum Total Cholesterol and Mortality

Confounding Factors and Risk Modification in Japanese-American Men

Carlos Iribarren, MD, MPH, PhD; Dwayne M. Reed, MD, PhD; Cecil M. Burchfiel, PhD; James H. Dwyer, PhD

JAMA. 1995;273(24):1926-1932.


Abstract

Objective.
—To further investigate the relationship between serum total cholesterol (TC) level and mortality due to major causes. In particular, is the elevated mortality among persons with low TC levels due to confounding conditions that both lower TC level and increase the risk of mortality, and is the association between low or high TC level and mortality homogeneous in the population or, alternatively, restricted to persons with other risk factors?

Study Design.
—Prospective cohort study.

Setting.
—Free-living population in Oahu, Hawaii.

Participants.
—A total of 7049 middle-aged men of Japanese ancestry.

Main Outcome Measures.
—Age- and risk factor—adjusted mortality due to coronary heart disease, hemorrhagic stroke, cancer, chronic obstructive pulmonary disease, nonmalignant liver disease, trauma, miscellaneous and unknown, and all causes.

Results.
—During 23 years of follow-up, a total of 1954 deaths were documented (38% cancer, 25% cardiovascular, and 37% other). Men with low serum TC levels (<4.66 mmol/L [<180 mg/dL]) were found to have several adverse health characteristics, including a higher prevalence of current smoking, heavy drinking, and certain gastrointestinal conditions. In an age-adjusted model, and in relation to the reference group (4.66 to 6.19 mmol/L [180 to 239 mg/dL]), those in the lowest TC group (<4.66 mmol/L [<180 mg/dL]) were at significantly higher risk of mortality due to hemorrhagic stroke (relative risk [RR], 2.41; 95% confidence interval [CI], 1.45 to 4.00), cancer (RR, 1.41; 95% CI, 1.17 to 1.69), and all causes (RR, 1.23; 95% CI, 1.09 to 1.38). Adjustment for confounders in multivariate analysis (and exclusion of cases with prevalent disease at baseline and deaths through year 5) did not explain the risk of fatal hemorrhagic stroke but reduced the excess risk of cancer mortality by 51% (to 1.20 from 1.41) and reduced the excess risk of all-cause mortality by 56% (to 1.10 from 1.32) in the low TC group. In addition, there were clear differences in the patterns of risk when comparing men with and without selected risk factors (ie, smoking, alcohol consumption, and untreated hypertension).

Conclusions.
—We conclude that the excess mortality at low TC levels can be partially explained by confounding with other determinants of death and by preexisting disease at baseline, and TC-mortality associations are not homogeneous in the population. In our study, TC level was not associated with increased cancer or all-cause mortality in the absence of smoking, high alcohol consumption, and untreated hypertension.

(JAMA. 1995;273:1926-1932)



Author Affiliations

From the Institute for Health Promotion and Disease Prevention Research, Department of Preventive Medicine (Drs Iribarren and Dwyer) and the Atherosclerosis Research Institute, Department of Medicine (Dr Dwyer), University of Southern California School of Medicine, Los Angeles; the Buck Center for Research on Aging, Novato, Calif (Dr Reed); and Honolulu (Hawaii) Heart Program and National Heart, Lung, and Blood Institute, Bethesda, Md (Dr Burchfiel).


Footnotes

Presented in part at the 33rd Annual Conference on Cardiovascular Disease Epidemiology and Prevention, Santa Fe, NM, March 19, 1993, and received the American Heart Association Jeremiah Stamler Research Award for New Investigators.

Reprint requests to Institute for Prevention Research, Department of Preventive Medicine, University of Southern California School of Medicine, 1540 Alcazar St, CHP 205E, Los Angeles, CA 90033 (Dr Dwyer).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Low-Density Lipoprotein Cholesterol Concentrations and Death Due to Intraparenchymal Hemorrhage: The Ibaraki Prefectural Health Study
Noda et al.
Circulation 2009;119:2136-2145.
ABSTRACT | FULL TEXT  

Total Cholesterol, Severity of Stroke, and All-Cause Mortality
Sheikh
Stroke 2008;39:e61-e62.
FULL TEXT  

Associations Between Serum Lipids and Causes of Mortality in a Cohort of 3499 Urban Thais: The Electricity Generating Authority of Thailand (EGAT) Study
Sritara et al.
ANGIOLOGY 2008;58:757-763.
ABSTRACT  

Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study
Ebrahim et al.
BMJ 2006;333:22.
ABSTRACT | FULL TEXT  

Association Between Cholesterol Level and Mortality in Dialysis Patients: Role of Inflammation and Malnutrition
Liu et al.
JAMA 2004;291:451-459.
ABSTRACT | FULL TEXT  

Effects of Cholesterol and Inflammation-Sensitive Plasma Proteins on Incidence of Myocardial Infarction and Stroke in Men
Engstrom et al.
Circulation 2002;105:2632-2637.
ABSTRACT | FULL TEXT  

Estimating the Effect of Cardiovascular Risk Factors on All-Cause Mortality and Incidence of Coronary Heart Disease Using G-Estimation: The Atherosclerosis Risk in Communities Study
Tilling et al.
Am J Epidemiol 2002;155:710-718.
ABSTRACT | FULL TEXT  

Better outcome after stroke with higher serum cholesterol levels
Vauthey et al.
Neurology 2000;54:1944-1949.
ABSTRACT | FULL TEXT  

Vegetable Oils High in Phytosterols Make Erythrocytes Less Deformable and Shorten the Life Span of Stroke-Prone Spontaneously Hypertensive Rats
Ratnayake et al.
J. Nutr. 2000;130:1166-1178.
ABSTRACT | FULL TEXT  

Association of low plasma cholesterol with mortality for cancer at various sites in men: 17-y follow-up of the prospective Basel study1
Eichholzer et al.
Am. J. Clin. Nutr. 2000;71:569-574.
ABSTRACT | FULL TEXT  

Differences in Prevalence of and Risk Factors for Subclinical Vascular Disease Among Black and White Participants in the Cardiovascular Health Study
Kuller et al.
Arterioscler. Thromb. Vasc. Bio. 1998;18:283-293.
ABSTRACT | FULL TEXT  

The Munster Heart Study (PROCAM) : Total Mortality in Middle-Aged Men Is Increased at Low Total and LDL Cholesterol Concentrations in Smokers but Not in Nonsmokers
Cullen et al.
Circulation 1997;96:2128-2136.
ABSTRACT | FULL TEXT  

Serum Cholesterol and Mortality Rates in a Native American Population With Low Cholesterol Concentrations : A U-Shaped Association
Fagot-Campagna et al.
Circulation 1997;96:1408-1415.
ABSTRACT | FULL TEXT  

Total, LDL, and HDL Cholesterol Decrease With Age in Older Men and Women : The Rancho Bernardo Study 1984–1994
Ferrara et al.
Circulation 1997;96:37-43.
ABSTRACT | FULL TEXT  

Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: A French community-based study
Berr et al.
Proc. Natl. Acad. Sci. USA 1996;93:13410-13415.
ABSTRACT | FULL TEXT  

Low Total Serum Cholesterol and Intracerebral Hemorrhagic Stroke: Is the Association Confined to Elderly Men?: The Kaiser Permanente Medical Care Program
Iribarren et al.
Stroke 1996;27:1993-1998.
ABSTRACT | FULL TEXT  

Carcinogenicity of Lipid-Lowering Drugs
Newman and Hulley
JAMA 1996;275:55-60.
ABSTRACT  

Low Serum Cholesterol and Mortality : Which Is the Cause and Which Is the Effect?
Iribarren et al.
Circulation 1995;92:2396-2403.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.